Eldon C. Mayer Iii.
EVP &Chief Commercial Officer, RIGEL PHARMACEUTICALS INC.
Companies
- Eiger BioPharmaceuticals, Inc.Ex VP & Chief Commerc. Officer Jan 30, 2020 to Mar 21, 20231
- RIGEL PHARMACEUTICALS INCEVP &Chief Commercial Officer Oct 11, 2016 to Nov 20, 20192
- Eiger BioPharmaceuticals, Inc.Board member Jan 9, 2018 to Mar 25, 20193
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Eiger BioPharmaceuticals, Inc.56,073 shares4Mar 17, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 17, 2023Sold 1,875 shares at $1.07 of Eiger BioPharmaceuticals, Inc.4
- Mar 17, 2023Sold 2,520 shares at $1.07 of Eiger BioPharmaceuticals, Inc.4
- Mar 14, 2022Sold 1,657 shares at $5.60 of Eiger BioPharmaceuticals, Inc.5
- Mar 11, 2022Granted 16,000 shares of Eiger BioPharmaceuticals, Inc.6
- Jan 7, 2022Sold 1,560 shares at $4.95 of Eiger BioPharmaceuticals, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Mar 14, 2022
- 6SEC EDGARForm 4 filed Mar 11, 2022
- 7SEC EDGARForm 4 filed Jan 11, 2022